EP2167126 - LYOPHILIZED IMMUNOGLOBULIN FORMULATIONS AND METHODS OF PREPARATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.01.2013 Database last updated on 24.08.2024 | Most recent event Tooltip | 25.01.2013 | Application deemed to be withdrawn | published on 27.02.2013 [2013/09] | Applicant(s) | For all designated states Elan Pharmaceuticals Inc. 800 Gateway Boulevard South San Francisco, CA 94080 / US | [2010/13] | Inventor(s) | 01 /
O'CONNOR, Barbara, Horsey 150 Dale Avenue San Carlos, CA 94070 / US | 02 /
BUCKLEY, Shaun, E. 427 Stockton Street, 809 San Francisco, CA 94108 / US | 03 /
BURKE, David, J. 5957 Chabolyn Terrace Oakland, CA 94618 / US | 04 /
LEHRMAN, Sherwood Russ 1731 Penny Way Los Altos, CA 94024 / US | [2010/26] |
Former [2010/13] | 01 /
O'CONNOR, Barbara, Horsey 150 Dale Avenue San Carlos, CA 94070 / US | ||
02 /
BUCKLEY, Shaun, E. 427 Stockton Street, 809 San Francisco, CA 94108 / US | |||
03 /
BURKE, David, J. 5957 Chabolyn Terrace Oakland, CA 94618 / US | |||
04 /
LEHRMAN, Russ, Sherwood 1731 Penny Way Los Altos, CA 94024 / US | Representative(s) | Schüssler, Andrea, et al Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [N/P] |
Former [2010/43] | Schüssler, Andrea, et al Patentanwälte Huber & Schüssler Truderinger Strasse 246 81825 München / DE | ||
Former [2010/13] | Warcoin, Jacques Cabinet Régimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | Application number, filing date | 08771083.6 | 13.06.2008 | [2010/13] | WO2008US66990 | Priority number, date | US20070929133P | 14.06.2007 Original published format: US 929133 P | US20080138075 | 12.06.2008 Original published format: US 138075 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2008157409 | Date: | 24.12.2008 | Language: | EN | [2008/52] | Type: | A1 Application with search report | No.: | EP2167126 | Date: | 31.03.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.12.2008 takes the place of the publication of the European patent application. | [2010/13] | Search report(s) | International search report - published on: | US | 24.12.2008 | (Supplementary) European search report - dispatched on: | EP | 06.02.2012 | Classification | IPC: | A61K39/395, C07K16/28, A61K9/19 | [2012/10] | CPC: |
A61K39/39591 (EP,US);
A61K9/19 (EP,US);
A61P37/00 (EP);
C07K16/2839 (EP,US);
A61K2039/505 (EP,US);
C07K2317/24 (EP,US)
|
Former IPC [2010/13] | A61K39/395, G01N33/574 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/13] | Extension states | AL | 13.01.2010 | BA | 13.01.2010 | MK | 13.01.2010 | RS | 13.01.2010 | Title | German: | LYOPHILISIERTE IMMUNOGLOBULIN-FORMULIERUNGEN UND HERSTELLUNGSVERFAHREN DAFÜR | [2010/13] | English: | LYOPHILIZED IMMUNOGLOBULIN FORMULATIONS AND METHODS OF PREPARATION | [2010/13] | French: | FORMULATIONS D'IMMUNOGLOBULINE LYOPHILISEES ET PROCEDES DE PREPARATION | [2010/13] | Entry into regional phase | 13.01.2010 | National basic fee paid | 13.01.2010 | Search fee paid | 13.01.2010 | Designation fee(s) paid | 13.01.2010 | Examination fee paid | Examination procedure | 13.01.2010 | Examination requested [2010/13] | 16.01.2010 | Amendment by applicant (claims and/or description) | 05.09.2012 | Application deemed to be withdrawn, date of legal effect [2013/09] | 11.10.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/09] | Fees paid | Renewal fee | 11.06.2010 | Renewal fee patent year 03 | 13.06.2011 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.06.2012 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO03009817 (PROTEIN DESIGN LABS INC [US], et al) [A] 1-16 * abstract *; | [X]WO2004071439 (ELAN PHARM INC [US], et al) [X] 1-16 * page 25, line 25 - page 26, line 2 *; | [A] - SHEREMATA W A ET AL, "A Safety and Pharmacokinetic Study of Intravenous Natalizumab in Patients with MS", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, (19990301), vol. 52, no. 5, ISSN 0028-3878, pages 1072 - 1074, XP002997442 [A] 1-16 * abstract * | [A] - DAUGHERTY A L ET AL, "Formulation and delivery issues for monoclonal antibody therapeutics", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 58, no. 5-6, doi:10.1016/J.ADDR.2006.03.011, ISSN 0169-409X, (20060807), pages 686 - 706, (20060807), XP024892149 [A] 1-16 * the whole document * * in particular table 1 * DOI: http://dx.doi.org/10.1016/j.addr.2006.03.011 | [A] - WANG W ET AL, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN PHARMACEUTICAL ASSOCIATION, WASHINGTON, US, (20070101), vol. 96, no. 1, doi:10.1002/JPS.20727, ISSN 0022-3549, pages 1 - 26, XP009084505 [A] 1-16 * the whole document * * in particular table 1 * DOI: http://dx.doi.org/10.1002/jps.20727 | International search | [Y]US6306404 (LAPOSTA VINCENT JAMES [US], et al); | [X]US2005053598 (BURKE DAVID J [US], et al); | [Y]US2006008415 (KAISHEVA ELISABET A [US], et al) |